Search results for:
tolvaptan
tolvaptan
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Jynarque |
TABLET, ORAL |
15 mg, 30 mg, 45 mg, 60 mg, 90 mg |
|
|
|
|
| Samsca |
TABLET, ORAL |
15 mg, 30 mg |
|
|
|
|
Last updated: Nov. 24, 2025
Jynarque medication guide
Samsca medication guide
SAMSCA is classified as formulary, restricted to cardiology, CV surgery, nephrology, or endocrinology.
Jynarque is non-formulary, not stocked. Drug is only distributed directly to the patient from a specialty pharmacy. If ordered for continuation of home use in the hospital, a nephrology consult is recommended. Inpatients should use their own Jynarque if at all possible, rather than Samsca tablets.
Reviewed: August 25, 2009, and 23 Oct 2018 (Jynarque)
Updated: May 2019 (PKS automatic consultation discontinued)
REMS (tolvaptan for ADPKD): View FDA REMS Info